256 related articles for article (PubMed ID: 25241635)
1. Safety of an ED High-Dose Opioid Protocol for Sickle Cell Disease Pain.
Tanabe P; Martinovich Z; Buckley B; Schmelzer A; Paice JA
J Emerg Nurs; 2015 May; 41(3):227-35. PubMed ID: 25241635
[TBL] [Abstract][Full Text] [Related]
2. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
[TBL] [Abstract][Full Text] [Related]
3. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
Mathias MD; McCavit TL
Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
[TBL] [Abstract][Full Text] [Related]
4. Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.
Tanabe P; Hafner JW; Martinovich Z; Artz N
Acad Emerg Med; 2012 Apr; 19(4):430-8. PubMed ID: 22506947
[TBL] [Abstract][Full Text] [Related]
5. Pain management in adults with sickle cell disease in a medical center emergency department.
Solomon LR
J Natl Med Assoc; 2010 Nov; 102(11):1025-32. PubMed ID: 21141290
[TBL] [Abstract][Full Text] [Related]
6. Oral morphine protocol for sickle cell crisis pain.
Conti C; Tso E; Browne B
Md Med J; 1996 Jan; 45(1):33-5. PubMed ID: 8569458
[TBL] [Abstract][Full Text] [Related]
7. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM
Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
[TBL] [Abstract][Full Text] [Related]
8. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
[TBL] [Abstract][Full Text] [Related]
9. Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease.
Givens M; Rutherford C; Joshi G; Delaney K
J Emerg Med; 2007 Apr; 32(3):239-43. PubMed ID: 17394984
[TBL] [Abstract][Full Text] [Related]
10. Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain.
Glassberg J; Simon J; Patel N; Jeong JM; McNamee JJ; Yu G
Am J Emerg Med; 2015 Oct; 33(10):1396-401. PubMed ID: 26283616
[TBL] [Abstract][Full Text] [Related]
11. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
[TBL] [Abstract][Full Text] [Related]
12. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.
Molokie RE; Montminy C; Dionisio C; Farooqui MA; Gowhari M; Yao Y; Suarez ML; Ezenwa MO; Schlaeger JM; Wang ZJ; Wilkie DJ
Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541
[TBL] [Abstract][Full Text] [Related]
13. The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain.
Muslu CS; Kopetsky M; Nimmer M; Visotcky A; Fraser R; Brousseau DC
Pediatr Blood Cancer; 2020 Sep; 67(9):e28268. PubMed ID: 32614150
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
Wilson TT; Chou SC; Becker S; Schuur JD; Beaudoin F
Am J Emerg Med; 2021 Dec; 50():597-601. PubMed ID: 34592567
[TBL] [Abstract][Full Text] [Related]
15. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
16. A Standardized Emergency Department Order Set Decreases Admission Rates and In-Patient Length of Stay for Adults Patients with Sickle Cell Disease.
Wachnik AA; Welch-Coltrane JL; Adams MCB; Blumstein HA; Pariyadath M; Robinson SG; Saha A; Summers EC; Hurley RW
Pain Med; 2022 Dec; 23(12):2050-2060. PubMed ID: 35708651
[TBL] [Abstract][Full Text] [Related]
17. Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department.
Gonzalez ER; Bahal N; Hansen LA; Ware D; Bull DS; Ornato JP; Lehman ME
Arch Intern Med; 1991 Jul; 151(7):1373-8. PubMed ID: 2064488
[TBL] [Abstract][Full Text] [Related]
18. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
19. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.
Barrett MJ; Cronin J; Murphy A; McCoy S; Hayden J; an Fhailí S; Grant T; Wakai A; McMahon C; Walsh S; O'Sullivan R
Trials; 2012 May; 13():74. PubMed ID: 22647439
[TBL] [Abstract][Full Text] [Related]
20. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
